Vertex Pharmaceuticals · Total Non-Current Liabilities

Latest reported$3.62Bperiod endingDec 31, 2025

VRTX FY Total Non-Current Liabilities ($2.40M → $3.62B)

Annual total non-current liabilities

High-resolution chart · PNG

VRTX total non-current liabilities history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Total Non-Current Liabilities — Annual fiscal periods (USD)
Period ending	Total Non-Current Liabilities (USD)
Dec 31, 2025	3,615,800,000
Dec 31, 2024	2,559,000,000
Dec 31, 2023	1,602,400,000
Dec 31, 2022	1,496,100,000
Dec 31, 2021	1,190,500,000
Dec 31, 2020	1,187,500,000
Dec 31, 2019	898,394,000
Dec 31, 2018	690,403,000
Dec 31, 2017	696,448,000
Dec 31, 2016	766,059,000
Dec 31, 2015	898,792,000
Dec 31, 2014	870,242,000
Dec 31, 2013	564,807,000
Dec 31, 2012	1,130,812,000
Dec 31, 2011	883,456,000
Dec 31, 2010	746,690,000
Dec 31, 2009	574,259,000
Dec 31, 2008	525,041,000
Dec 31, 2007	130,903,000
Dec 31, 2006	164,630,000
Dec 31, 2005	209,579,000
Dec 31, 2004	356,267,000
Dec 31, 2003	392,499,000
Dec 31, 2002	372,542,000
Dec 31, 2001	358,227,000
Dec 31, 2000	357,269,000
Dec 31, 1999	4,693,000
Dec 31, 1998	7,000,000
Dec 31, 1997	5,900,000
Dec 31, 1996	5,600,000
Dec 31, 1995	4,900,000
Dec 31, 1994	4,700,000
Dec 31, 1993	4,200,000
Dec 31, 1992	3,200,000
Dec 31, 1991	2,200,000
Dec 31, 1990	2,400,000